» Articles » PMID: 1124762

Hereditary Persistence of Fetal Hemoglobin, Beta Thalassemia, and the Hemoglobin Delta-beta Locus: Further Family Data and Genetic Interpretations

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1975 Mar 1
PMID 1124762
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Three Negro kindreds with hereditary persistence of fetal hemoglobin (HPFH) alone and in combination with various other hemoglobin abnormalities including beta thalassemia are presented. Among 11 offspring of two women heterozygous for both HPFH and the delta chain mutation Hb B2, five inherited the HPFH gene and six inherited the Hb B2 gene. In another kindred, a man inferred to be heterozygous for both HPFH and Hb C had six children; three offsprivg obtained the Hb C gene and three the HPFH gene. Similarly, a woman heterozygous for both Hb S and HPFH transmitted the Hb S gene to one of her two children and the HPFH gene to the other. Thus among 19 offspring, no crossovers between the HPFH locus or the Hb delta-beta locus were observed. These and earlier data are compatible with deletion of the Hb beta and delta loci as the primary event to explain the genetic origin of HPFH. Genetic considerations indicate that the finding of a single person with a hematologically normal phenotype among offspring of heterozygotes for both the African type of HPFH and a Hb beta or Hb delta structural abnormality would invalidate the deletion model.

Citing Articles

Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4 and CD8 T cells.

Zurlo M, Nicoli F, Proietto D, Dallan B, Zuccato C, Cosenza L J Cell Mol Med. 2023; 27(3):353-364.

PMID: 36625233 PMC: 9889681. DOI: 10.1111/jcmm.17655.


Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease.

Cannon M, Phillips H, Smith S, Williams K, Brinton L, Gregory C J Clin Med. 2020; 9(7).

PMID: 32708954 PMC: 7408993. DOI: 10.3390/jcm9072276.


A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.

Howard J, Hemmaway C, Telfer P, Layton D, Porter J, Awogbade M Blood. 2019; 133(17):1865-1875.

PMID: 30655275 PMC: 6484388. DOI: 10.1182/blood-2018-08-868893.


Clinical genetics: ghanaian gratitude for british and hungarian contributions: a personalized historical perspective.

Konotey-Ahulu F Ghana Med J. 2011; 43(4):175-8.

PMID: 21326998 PMC: 2956372.

References
1.
SMITHIES O . CHARACTERIZATION OF GENETIC VARIANTS OF BLOOD PROTEINS. Vox Sang. 1965; 10:359-62. View

2.
Motulsky A . Controller genes in synthesis of human haemoglobin. Nature. 1962; 194:607-9. DOI: 10.1038/194607b0. View

3.
Neel J . The hemoglobin genes: a remarkable example of the clustering of related genetic functions on a single mammalian chromosome. Blood. 1961; 18:769-77. View

4.
Pearson H, Moore M . HUMAN HEMOGLOBIN GENE LINKAGE: REPORT OF A FAMILY WITH HEMOGLOBIN B2, HEMOGLOBIN S, AND BETA THALASSEMIA, INCLUDING A PROBABLE CROSSOVER BETWEEN THALASSEMIA AND DELTA LOCI. Am J Hum Genet. 1965; 17:125-32. PMC: 1932359. View

5.
FESSAS P, Stamatoyannopoulos G . HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN IN GREECE. A STUDY AND A COMPARISON. Blood. 1964; 24:223-40. View